Parkman’s $19.88M EyePoint Bet: Smart Capital or Risky Hype?
Parkman Healthcare Partners made a decisive $19.88 million institutional bet on EyePoint Pharmaceuticals (NASDAQ:EYPT) by acquiring more than 1.08 million […]
Analysis
57.4% HIMS Growth Fueled by Novo Nordisk Alliance
Hims & Hers Health Inc. stunned the market with a 57.4% week-on-week surge in its share price, a rally powered
Adobe Tumbles 12.1% After $6.40B Q1 and CEO Exit Signal
Adobe (NASDAQ: ADBE) fell 12.1% in market value following its first-quarter fiscal 2026 announcement reporting revenue of US$6.40 billion and